Review/Foreign exchange

Roche

An in-depth look at the primary market's most innovative transactions. This month: the $16bn deal from Swiss pharma firm Roche, and Westpac's yen issue

Deals of the Month: GDF Suez

The primary markets have been buzzing since the start of the year. We profile GDF Suez's mammoth EUR4.25bn deal, the $1.5bn five-year from Staples, and Toyota's Swiss franc issue

Deals of the Month: Staples

One of the most encouraging aspects of the strong pace of corporate issuance in the dollar market in January, in addition to the sheer volume of new paper, was the willingness of investors to leave the security of the investment grade's higher echelons…

High coupons, high volatility

BNP Paribas has released dispersion products that are based on euro rates, a global emerging markets currency basket and global money market rates. Capital is protected and the annual income on offer has the potential to exceed the risk-free rate

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here